D1 but not D4 Dopamine Receptors are Critical for MDMA-Induced Neurotoxicity in Mice

被引:13
作者
Granado, N. [1 ,2 ]
Ares-Santos, S. [1 ,2 ]
Moratalla, R. [1 ,2 ]
机构
[1] CSIC, Inst Cajal, Consejo Super Invest Cient, E-28002 Madrid, Spain
[2] Inst Salud Carlos III, CIBERNED, Madrid, Spain
关键词
Amphetamine derivatives; Methamphetamine; Methcathinone; DAT; Drug addiction; Parkinson's disease; Striatum; TH; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; TRANSPORTER FUNCTION; NEURONAL INCLUSIONS; SUBSTANTIA-NIGRA; METHAMPHETAMINE; ECSTASY; DAMAGE; BRAIN; METHYLENEDIOXYMETHAMPHETAMINE; MECHANISMS;
D O I
10.1007/s12640-013-9438-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MDMA, an addictive psychostimulant-consumed worldwide, has the ability to induce neurotoxic effects and addiction in laboratory animals and in humans through its effects on monoaminergic systems. MDMA-induced neurotoxicity in mice occurs primarily in dopaminergic neurons and does not significantly affect the serotonergic system. As the neurotoxic effects of MDMA in mice involve excessive dopamine (DA) release, DA receptors are highly likely to play a role in MDMA neurotoxicity, but the specific dopamine receptor subtypes involved have not previously been determined definitively. In this study, dopamine D1 and D4 receptor knock-out mice (D1R(-/-) and D4R(-/-)) were used to determine whether these receptors are involved in MDMA neurotoxicity. D1R inactivation attenuated MDMA-induced hyperthermia, decreased the reduction of dopamine and dopamine metabolite levels, and protected against dopamine terminal loss and reactive astrogliosis as determined in the striatum, 7 days after MDMA treatment. In sharp contrast, inactivation of D4R did not prevent hyperthermia or the neurotoxic effects of MDMA. Altogether, these results indicate that D1R, but not D4R, plays a significant role in the dopaminergic striatal neurotoxicity observed after exposure to MDMA.
引用
收藏
页码:100 / 109
页数:10
相关论文
共 58 条
[1]  
Albers DS, 1995, J PHARMACOL EXP THER, V275, P1104
[2]  
[Anonymous], 2012, WORLD DRUG REP
[3]   New Strategies in Neuroprotection and Neurorepair [J].
Antonelli, Marta C. ;
Guillemin, Gilles J. ;
Raisman-Vozari, Rita ;
Del-Bel, Elaine A. ;
Aschner, Michael ;
Collins, Michael A. ;
Tizabi, Yousef ;
Moratalla, Rosario ;
West, Adrian K. .
NEUROTOXICITY RESEARCH, 2012, 21 (01) :49-56
[4]   The role of dopamine receptors in the neurotoxicity of methamphetamine [J].
Ares-Santos, S. ;
Granado, N. ;
Moratalla, R. .
JOURNAL OF INTERNAL MEDICINE, 2013, 273 (05) :437-453
[5]   Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine [J].
Ares-Santos, S. ;
Granado, N. ;
Oliva, I. ;
O'Shea, E. ;
Martin, E. D. ;
Colado, M. I. ;
Moratalla, R. .
NEUROBIOLOGY OF DISEASE, 2012, 45 (02) :810-820
[6]   Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining [J].
Ares-Santos, Sara ;
Granado, Noelia ;
Espadas, Isabel ;
Martinez-Murillo, Ricardo ;
Moratalla, Rosario .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 (05) :1066-1080
[7]   A new brain area affected by 3,4-methylenedioxymethamphetamine: A microdialysis-biotelemetry study [J].
Benamar, Khalid ;
Geller, Ellen B. ;
Adler, Martin W. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 596 (1-3) :84-88
[8]  
BROENING HW, 1995, J PHARMACOL EXP THER, V275, P325
[9]   Free radicals and the pathobiology of brain dopamine systems [J].
Cadet, JL ;
Brannock, C .
NEUROCHEMISTRY INTERNATIONAL, 1998, 32 (02) :117-131
[10]   Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview [J].
Capela, Joao Paulo ;
Carmo, Helena ;
Remiao, Fernando ;
Bastos, Maria Lourdes ;
Meisel, Andreas ;
Carvalho, Felix .
MOLECULAR NEUROBIOLOGY, 2009, 39 (03) :210-271